期刊文献+

奥沙利铂联合5-FU、LV治疗直肠癌术后26例临床观察 被引量:3

下载PDF
导出
摘要 目的:观察奥沙利铂(L-OHP)联合氟尿嘧啶(5-FU)及亚叶酸钙(LV)治疗术后直肠癌的疗效和不良反应。方法:26例直肠癌术后患者,采用L-OHP联合5-FU及LV方案治疗,每月重复1次,治疗3个周期后评价疗效。结果:26例中,完全缓解3例(11.5%),部分缓解18例(69.2%),近期有效率80.8%。主要不良反应为恶心、乏力、感觉神经毒性和腹泻,无化疗相关死亡。结论:L-OHP联合5-FU及LV方案治疗术后直肠癌疗效显著,安全性高,不良反应经处理后均可耐受,无严重不良反应发生,可作为一种供选择方案。
出处 《西南国防医药》 CAS 2008年第6期872-873,共2页 Medical Journal of National Defending Forces in Southwest China
  • 相关文献

参考文献7

  • 1FOLPRECHT G,KOHNE C H. The role of new agengts in the treatment of eolorectal caneer[J]. Oncology, 2004,66 (1) : 1 - 17.
  • 2应杰儿,钟海均,冯海洋.FOLFOX4方案治疗晚期大肠癌的临床观察[J].肿瘤防治杂志,2005,12(18):1423-1424. 被引量:28
  • 3AHNED F E.Molecular markers that predict response colon cancer therapy[J]. Expert Rev Mol Diagn,2005,5(3):353 - 375.
  • 4FOLPRECHT G,KOHNE C H. The role of new agengts in the treatment of colorectal cancer[J]. Oncology, 2004,66 (1) : 1 - 17.
  • 5卓越.新编临床药物实用手册[M].北京:科学出版社,2004:256-266.
  • 6RAYMOND E,FAIVRE S,CHANEY S, et al.Cellular and molecular - pharmacology of oxaliplatin[J]. Mol Cancer Ther, 2002,1(3):227- 235.
  • 7林万隆,陈强.奥沙利铂的药理作用及临床应用[J].中国肿瘤临床,2000,27(11):872-874. 被引量:333

二级参考文献12

  • 1张文,许立功.晚期结直肠癌的化疗进展[J].中国癌症杂志,2004,14(4):378-382. 被引量:25
  • 2陆仰东.国产奥沙利铂为主的联合化疗治疗51例晚期大肠癌疗效观察[J].中国肿瘤临床,2004,31(24):1401-1403. 被引量:5
  • 3Li X M,Arch Toxicol,1998年,72卷,9期,574页
  • 4Goldstein D, Mitchell P, Michal M, et al. Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer Patients[J]. Br J Cancer,2005, 92(5) :832-837.
  • 5Hsuen Lim E, Seng Cheong Lim R, Seng Wu T, et al. Oxaliplatin/fluorouracil/leucovorin in advanced colorectal carcinoma:an asian experience[J]. Pann Pharmacother,2003,37(12) :1909-1912.
  • 6Kemeny N, Garay C A, Gurtler J, et al. Randomized multicenter phase Ⅱ trial of bolus plus in FU sional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer [J]. J Clin Oncol,2005,23(1) :248-252.
  • 7Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics,2002[J]. CA Cancer J Clin, 2005, 55(2) :74-108.
  • 8Rixe O, Ortuzar W,Alvarez M, et al. Oxaliplatin,tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug resistant celllines and in the cell lines of the National Cancer Institute ' s Anticancer Drug Screen panel[J]. Biochem Pharmacol, 1996,52 (12): 1855 -1865.
  • 9Kuebler J P,de Gramont A. Recent Experience With Oxaliplatin or lrinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer[J]. Semin Oncol,2004,30(4 Suppl 15) :40-47.
  • 10Simpson D, Dunn C, Curran M. Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer [J]. Drugs, 2003,63(19) :2127-2156.

共引文献354

同被引文献18

引证文献3

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部